Mallinckrodt inks deal to acquire Sucampo Pharmaceuticals
Mallinckrodt has signed an agreement to acquire US biopharma company Sucampo Pharmaceuticals, including…
Related Biotechnology, Pharmaceutical and Healthcare News
Original Article: Mallinckrodt inks deal to acquire Sucampo Pharmaceuticals
NEXT ARTICLE
More From BioPortfolio on "Mallinckrodt inks deal to acquire Sucampo Pharmaceuticals"